Skip Navigation LinksHome > March 2014 - Volume 36 - Issue 2 > Esthesioneuroblastoma in Children and Adolescent: Experienc...
Journal of Pediatric Hematology/Oncology:
doi: 10.1097/MPH.0000000000000095
Original Articles

Esthesioneuroblastoma in Children and Adolescent: Experience on 11 Cases With Literature Review

El Kababri, Maria MD; Habrand, Jean L. MD, PhD; Valteau-Couanet, Dominique MD, PhD; Gaspar, Nathalie MD, PhD; Dufour, Christelle MD; Oberlin, Odile MD

Collapse Box


Esthesioneuroblastoma is a rare tumor of the olfactory epithelium. This report analyzed 11 children and adolescents treated in a single institution between 1982 and 2002. For 9 patients, therapy consisted of an initial course of chemotherapy before surgical resection and postoperative radiotherapy, for 1 patient an initial course of chemotherapy before radiotherapy and for another resection before radiotherapy with no chemotherapy. Response to chemotherapy was assessed in 9 patients of whom 6 achieved a complete or a partial remission. Ten patients are long-term survivors. The 5-year actuarial disease-free survival and overall survival rate was 91% (95% confidence interval, 62%-98%). Our study indicates that esthesioneuroblastoma is sensitive to chemotherapy and supports the role of combined modalities including neoadjuvant chemotherapy, surgery, and radiation therapy.

Copyright © 2014 Wolters Kluwer Health, Inc. All rights reserved.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Connect With Us


For additional oncology content, visit LWW Oncology Journals on Facebook.